Merck’s Vioxx liability could reach $18 billion

Share this article:
Analysts have estimated that Merck's potential liability could reach $18 billion in lawsuits over its withdrawn COX-2 drug Vioxx, according to a report in today's Wall Street Journal.
A federal judge in New Orleans told lawyers yesterday that there could ultimately be up to 100,000 cases filed against Merck and that he could hear a case as early as this fall, the Journal report said.
The first cases are set to be heard in state courts – Texas in July and New Jersey in August – with a case in Alabama currently postponed. 
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.